Terms: = Thyroid cancer AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Prognosis
1387 results:
1. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
Qiu R; Fu J
Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
[TBL] [Abstract] [Full Text] [Related]
2. The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.
Lin Y; Cui N; Li F; Wang Y; Wang B
Front Endocrinol (Lausanne); 2024; 15():1330896. PubMed ID: 38745958
[TBL] [Abstract] [Full Text] [Related]
3. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract] [Full Text] [Related]
4. PON3::LCN1 and HTN3::MSANTD3 Gene Fusions With NR4A3/NR4A2 Expression in Salivary Acinic Cell Carcinoma.
Zhu L; Sun L; Zhang Y; Liu X; Li X; Zhou Z; Cui Y; Zhou CX; Li TJ
Am J Surg Pathol; 2024 Jun; 48(6):681-690. PubMed ID: 38682454
[TBL] [Abstract] [Full Text] [Related]
5. Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma.
Yu W; Liu H; Zhang Y; Liu M; Li W; Wang L; Li D
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):89-94. PubMed ID: 38650151
[TBL] [Abstract] [Full Text] [Related]
6. Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
Fang Q; Yuan J; Zhang X; Dai L; Luo R; Xu C
Oral Oncol; 2024 May; 152():106810. PubMed ID: 38631065
[TBL] [Abstract] [Full Text] [Related]
7. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
8. Contents analysis of thyroid cancer-related information uploaded to YouTube by physicians in Korea: endorsing thyroid cancer screening, potentially leading to overdiagnosis.
Kang E; Ju H; Kim S; Choi J
BMC Public Health; 2024 Apr; 24(1):942. PubMed ID: 38566004
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a nomogram for predicting lymph node metastasis in ductal carcinoma in situ with microinvasion: A SEER population-based study.
Zhu K; Sui Y; Zhu M; Gao Y; Yuan Y; Sun P; Meng L; Dai J; Li Z
PLoS One; 2024; 19(4):e0301057. PubMed ID: 38557552
[TBL] [Abstract] [Full Text] [Related]
10. "Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.
Matošić Ž; Šimunović L; Jukić T; Granić R; Meštrović S
Prog Orthod; 2024 Mar; 25(1):12. PubMed ID: 38523193
[TBL] [Abstract] [Full Text] [Related]
11. MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival.
Molière S; Lodi M; Leblanc S; Gressel A; Mathelin C; Alpy F; Chenard MP; Tomasetto C
BMC Cancer; 2024 Mar; 24(1):295. PubMed ID: 38438841
[TBL] [Abstract] [Full Text] [Related]
12. Two Hematological Markers Predicting the Efficacy and prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast cancer.
Wang C; Shi Q; Zhang G; Wu X; Yan W; Wan A; Xiong S; Yuan L; Tian H; Ma D; Jiang J; Qi X; Zhang Y
Oncologist; 2024 May; 29(5):e635-e642. PubMed ID: 38431781
[TBL] [Abstract] [Full Text] [Related]
13. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis.
Gharzai LA; Morris E; Suresh K; Nguyen-Tân PF; Rosenthal DI; Gillison ML; Harari PM; Garden AS; Koyfman S; Caudell JJ; Jones CU; Mitchell DL; Krempl G; Ridge JA; Gensheimer MF; Bonner JA; Filion E; Dunlap NE; Stokes WA; Le QT; Torres-Saavedra P; Mierzwa M; Schipper MJ
Lancet Oncol; 2024 Mar; 25(3):366-375. PubMed ID: 38423050
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical characteristics and prognostic factors of breast cancer patients with tumor deposits in the ipsilateral axillary region].
Xiao JJ; Huang ML; Yan CJ; Ling R; Wei HL
Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):146-154. PubMed ID: 38418189
[No Abstract] [Full Text] [Related]
15. Construction of disulfidptosis-based immune response prediction model with artificial intelligence and validation of the pivotal grouping oncogene c-MET in regulating T cell exhaustion.
Li P; Wang S; Wan H; Huang Y; Yin K; Sun K; Jin H; Wang Z
Front Immunol; 2024; 15():1258475. PubMed ID: 38352883
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of airway stenting and nasogastric tube insertion in airway-esophageal fistula patients with airways compromised by advanced malignancy.
Wu X; Lu G; Luo LC; Wei H; Yi Q; Luo W
Clin Respir J; 2024 Feb; 18(2):e13737. PubMed ID: 38350674
[TBL] [Abstract] [Full Text] [Related]
17. Course and predictors of excellent response to therapy in patients with differentiated thyroid cancer at long-term follow-up.
Samargandy SA; Qorban GN; Aljadani AK; Almufarji SS; Azab AM; Merdad MA; Al-Hajeili MR; Samargandy SJ
Saudi Med J; 2024 Feb; 45(2):139-146. PubMed ID: 38309729
[TBL] [Abstract] [Full Text] [Related]
18. Intraventricular Cerebral Metastases: A Comprehensive Systematic Review.
Scalia G; Silven MP; Costanzo R; Porzio M; Maugeri R; Iacopino DG; Nicoletti GF; Umana GE
Anticancer Res; 2024 Feb; 44(2):453-462. PubMed ID: 38307552
[TBL] [Abstract] [Full Text] [Related]
19. BRAF V600E Mutation Lacks Association with Poorer Clinical prognosis in Papillary thyroid Carcinoma.
Lai HF; Hang JF; Kuo PC; Kuo CS; Yao SF; Chen JY; Lee CH
Ann Surg Oncol; 2024 May; 31(5):3495-3501. PubMed ID: 38300401
[TBL] [Abstract] [Full Text] [Related]
20. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
Fukuda N; Toda K; Suto H; Oki R; Wang X; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
Endocr J; 2024 Apr; 71(4):363-371. PubMed ID: 38296547
[TBL] [Abstract] [Full Text] [Related]
[Next]
